Endo International wants to buy Auxilium Pharmaceuticals for $28.10Staff writer ▼ | September 18, 2014
Endo International plc has delivered a proposal to acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. for a per share consideration of $28.10 in a cash and stock transaction valued at $2.2 billion.
Possible acquisition A cash and stock transaction valued at $2.2 billion
Under the terms of the proposal, the consideration would include an approximately equal mix of cash and Endo stock. Endo intends to fund the transaction through a combination of existing cash on hand and debt financing.
Endo's proposal is subject to the completion of its due diligence review and the negotiation of mutually acceptable definitive transaction agreements containing customary closing conditions. ■